How has been the historical performance of Sanofi India?

Answer:The historical performance of Sanofi India shows a decline in key financial metrics from December 2023 to December 2024.

Breakdown:
In December 2024, Sanofi India's net sales reached 2,013.20 Cr, slightly up from 1,996.10 Cr in December 2023. Total operating income also increased marginally to 2,013.20 Cr from 1,996.10 Cr. However, total expenditure rose to 1,522.40 Cr from 1,508.40 Cr, leading to an operating profit (PBDIT) of 507.30 Cr, down from 548.90 Cr the previous year. Profit before tax decreased to 431.40 Cr from 528.50 Cr, and profit after tax fell to 313.70 Cr compared to 364.60 Cr in the prior year. The net profit also declined significantly to 413.30 Cr from 602.90 Cr. The earnings per share (EPS) dropped to 179.7 from 262.13, reflecting a decrease in profitability. On the balance sheet, total liabilities decreased to 1,611.70 Cr from 1,714.80 Cr, while total assets also fell to 1,611.70 Cr from 1,714.80 Cr. Cash flow from operating activities improved to 461.00 Cr from 230.00 Cr, but cash and cash equivalents decreased to 283.00 Cr from 394.00 Cr, indicating a challenging liquidity position. Overall, the financial performance of Sanofi India in 2024 reflects a downward trend in profitability and cash reserves despite slight growth in sales.